GlassScriptPhysician profile
John D Maskill
NPI 1669422077
$201,974.00
in general payments reported to CMS, 2019-2025
12 companies · $71K in 2025
The $71K reported for 2025 was more than what 93% of Foot and Ankle Surgery providers received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,473 · 2020: $3,756 · 2021: $1,940 · 2022: $4,877 · 2023: $85K · 2024: $34K · 2025: $71K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $150K · Travel and Lodging: $30K · Food and Beverage: $10K · Entertainment: $35.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $149,922.50 |
| Travel and Lodging | $29,882.54 |
| Food and Beverage | $10,088.81 |
| Entertainment | $35.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $141,547.27 | 2019-2025 | Ortholoc 3di, Ortholoc 2 Lapifuse, Augment Injectable |
| Paragon 28, INC. | $47,744.38 | 2022-2023 | Portfolio, Gorilla |
| Kuros Biosciences USA, INC | $4,276.12 | 2024-2025 | Magnetos |
| Wright Medical Technology, INC. | $3,071.34 | 2019-2020 | |
| Arthrex, INC. | $1,905.12 | 2020 | |
| Endo Pharmaceuticals INC. | $1,747.69 | 2024 | |
| Medwest Associates | $1,282.25 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $301.66 | 2019-2021 | |
| Heron Therapeutics, INC. | $44.83 | 2023 | Zynrelef |
| Abbott Laboratories | $29.00 | 2025 | Proclaim |
| Baxter Healthcare | $24.34 | 2023 | Floseal |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Maskill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.